ILLUMINA, INC.
ILMN · NASDAQ
Illumina is improving human health by unlocking the power of the genome. Its focus on innovation has established it as the global leader in DNA sequencing and array-based technologies, serving customers in the research, clinical, and applied markets. The Company products are used for applications in the life sciences, oncology, reproductive health, agriculture, and other emerging segments.
ESG Scores
Overall ESG7.4
Environmental10.0
Social6.6
Governance5.9
Gender Diversity
Female Directors0.3333%
Female Executives0.11267605633802817%
Women in Workforce0.44299999999999995%
CEO GenderMale